Last week, Netherlands-based medical device company Koninklijke Philips N.V settled a case brought against it by the U.S. Securities and Exchange Commission ("SEC") for violations of the Foreign Corrupt Practices Act ("FCPA") by its subsidiary in China.
You don't have access to this post on China Trade Monitor at the moment, but if you upgrade your account you'll be able to see the whole thing, as well as all the other posts in the archive! Subscribing only takes a few seconds and will give you immediate access.
This post is for subscribers only
Subscribe now
Already have an account? Sign in
